Cytokine profile of liver-infiltrating CD4+T cells separated from murine primary biliary cirrhosis-like hepatic lesions induced by graft- versus-host reaction

Journal of Gastroenterology and Hepatology (Australia)

Volumn 15, Issue 4, 2000, Pages 443-451

  Itoh, Shinichi ^a,b   Matsuzaki, Yasushi ^a   Kimura, Takeshi ^b,c   Ikegami, Tadashi ^a   Shoda, Junichi ^a   Fujiwara, Michio ^b   Tanaka, Naomi ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c Toride Ishikai Hospital   (Japan)

Author keywords

Graft versus host disease; Helper T cell subset; Interferon ; Interleukin 10; Primary biliary cirrhosis

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; FLOW CYTOMETRY; GRAFT VERSUS HOST REACTION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LYMPHOCYTIC INFILTRATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0034016964     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2000.02068.x     Document Type: Article

References (49)

1. Epstein O, Thomas HC, Sherlock S. Primary biliary cirrhosis is a 'dry gland' syndrome with features of chronic graft-versus-host disease. Lancet 1980; i: 1166-8.
2. Siegert W, Stemerowicz R, Hopf U. Antimitochondrial antibodies in patients with chronic graft-versus-host disease. Bone Marrow Transplant. 1992; 10: 221-7.
3. Gleichmann E, Pals ST, Relink AG, Radaszkiewicz T, Gleichmann H. Graft-versus-host reactions: Clues to the etiopathology of a spectrum of immunological diseases. Immunol. Today 1984; 5: 324-32.
4. Saitoh T, Fujiwara M, Asakura H. L3T4' T cells induce hepatic lesions resembling primary biliary cirrhosis in mice with graft versus host reactions due to major histocompatibility complex class II disparity. Clin. Immunol. Immunopathol. 1991; 59: 449-61.
5. Mosmann TR, Cherwinski H, Bond MW, Gieldin MA, Coffmann RL. Two types of murine helper T cell clone I. Definition according to profiles of lymphocyte activities and secreted proteins. J. Immunol. 1986; 136: 2348-57.
6. Cher DJ, Mosmann TR. Two types of murine helper T cell clone. II. Delayed-type hypersensitivity is mediated by Th1 clones. J. Immunol. 1987; 138: 3688-94.
7. Stout RD. Antigen-specific activation of effector macrophages by IFNγ-producing (Th1) T cell clones. J. Immunol. 1989; 142: 760-5.
8. Lohr HF, Schlaak JF, Gerken G, Fleischer B, Dienes H-P, Meyer zum Buschenfelde KH. Phenotypical analysis and cytokine release of liver-infiltrating and peripheral blood T lymphocytes from patients with chronic hepatitis of different etiology. Liver 1994; 14: 161-6.
9. Martinez OM, Villanueva JC, Gershwin ME. Cytokine patterns and cytotoxic mediators in primary biliary cirrhosis. Hepatology 1995; 21: 113-19.
10. Tsai SL, Lai MY, Chen DS. Analysis of rearranged T cell receptor (TCR) Vb transcripts in livers of primary biliary cirrhosis. Clin. Exp. Immunol. 1996; 103: 99-104.
11. Shindo M, Mullin GE, Braun-Elwert L. Cytokine mRNA expression in the liver of patients with primary biliary cirrhosis and chronic hepatitis B. Clin. Exp. Immunol. 1996; 105: 254-9.
12. Krams SM, Cao S, Hayashi M, Villanueva JC, Martinez OM. Elevations in IFN-γ, IL-5, IL-10 in patients with autoimmune disease primary biliary cirrhosis: Association with autoantibodies and soluble CD30. Clin. Immunol. Immunopathol. 1996; 80: 311-20.
13. Dumoulin FL, Bach A, Leifeld L et al. Semiquantitative analysis of intrahepatic cytokine mRNAs in chronic hepatitis C. J. Infect. Dis. 1997; 175: 681-5.
14. Berk PA. Cytokines in primary biliary cirrhosis. Semin. Liver Dis. 1997; 17: 115-23.
15. + T cells in semiallogeneic hosts with MHC class II disparity. J. Immunol. 1990; 145: 3268-75.
16. Saitoh T, Fujiwara M, Nomoto M, Kamimura T, Ishihara K, Kamimura T. Histologic studies on the hepatic lesions induced by graft-versus-host reaction in MHC class II disparate hosts compared with primary biliary cirrhosis. Am. J. Pathol. 1989; 135: 301-7.
17. Kimura T, Suzuki K, Inada S et al. Monoclonal antibody against lymphocyte function associated antigen 1 inhibits the formation of primary biliary cirrhosis like lesions induced by murine graft versus host reaction. Hepatology 1996; 24: 888-94.
18. Matsumoto Y, Fujiwara M. Adoptively transferred experimental allergic encephalomyelitis in chimeric rats. Immunology 1988; 65: 23-9.
19. Kawai K, Matsumoto Y, Watanabe H, Fujiwara M. Induction of cutaneous graft-versus-host disease by local injection of unprimed T cells. Clin. Exp. Immunol. 1991; 84: 359-66.
20. Watanabe H, Ohtsuka K, Kimura M et al. Details of an isolation method for hepatic lymphocytes in mice. J. Immunol. Methods 1992; 146: 145-54.
21. Goossens PL, Jouin H, Marchai G, Milon G. Isolation and flow cytometric analysis of the free lymphomyeloid cells present in murine liver. J. Immunol. Methods 1990; 132: 137-44.
22. + T cells in the presence of a nondepleting monoclonal antibody to CD4 induces a Th2 type response in vitro. J. Exp. Med. 1995; 182: 5-13.
23. Gershwin ME, Mackey IR. Primary biliary cirrhosis: Paradigm or paradox for autoimmunity. Gastroenterology 1991; 100: 822-33.
24. Shimizu M, Yuh K, Aoyama S et al. Immunohistochemical characterization of inflammatory infiltrates at the site of bile duct injury in primary biliary cirrhosis. Liver 1986; 6: 1-6.
25. Krams SM, Van de Water J, Coppel RL et al. Analysis of hepatic T lymphocyte and immunoglobulin deposits in patients with primary biliary cirrhosis. Hepatology 1990; 12: 306-13.
26. Itoh S. Delayed expression of T helper 2 type cytokine mRNA of liver infiltrating lymphocytes in murine model of primary biliary cirrhosis. Gastroenterology 1996; 110: A1219.
27. Maraskovsky E, Chen WF, Shortman K. IL2 and IFNγ are two necessary lymphokines in the development of cytolytic T cells. J. Immunol. 1989; 143: 1210-14.
28. Maeyer ED, Maeyer-Guignard JD. Interferons. In: Thomson A, ed. The Cytokine Handbook. San Diego: Academic Press. 1994; 265-88.
29. Hu W, Blazar BR, Manivel JC, Paradis K, Sharp HL. Phenotypical and functional characterization of intrahepatic bile duct cells from common duct ligated mice. J. Lab. Clin. Med. 1996; 128: 536-44.
30. Ayres RC, Neuberger JM, Shaw J, Joplin R, Adams DH. Intercellular adhesion molecule-1 and MHC antigens on human intrahepatic bile ducts cells: Effect of pro-inflammatory cytokines. Gut 1993; 34: 1245-9.
31. Farrar MA, Schreiber RD. The molecular cell biology of interferon-γ and its receptor. Ann. Rev. Immunol. 1993; 11: 571-611.
32. Harada K, Van de Water J, Leung P et al. In situ nucleic acid hybridization of cytokines in primary biliary cirrhosis. Predominance of the Th1 subset. Hepatology 1997; 25: 791-6.
33. Mosmann TR. Interleukin-10. In: Thomson A, ed. The Cytokine Handbook. San Diego: Academic Press. 1994; 223-37.
34. Briere F, Banchereau J. Interleukin-10 and B lymphocytes. In: de Vries JE, Malefyt RDW eds. Interleukin-10. Austin: RG Landes, 1995; 29-36.
35. Dobber R, Tielemans M, Nagelkerken L. The in vivo effects of neutralizing antibodies against IFN-γ, IL-4, IL-10 on the humoral immune response in young and aged mice. Cell. Immunol. 1995; 160: 185-92.
36. Marcelletti JF, Katz DH. IL-10 stimulates murine antigen-driven antibody responses in vitro by regulating helper cell subset participation. Cell. Immunol. 1996; 167: 86-98.
37. Fiorentino D, Bond M, Mosmann T. Two types of mouse T helper cell clone. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med. 1989; 170: 2081-95.
38. O'Garra A. Interleukin-10: An inhibitor of macrophage-dependent stimulation of Th1 cells. In: de Vries JE, Malefyt RDW, eds. Interleukin-10. Austin: RG Landes, 1995; 53-8.
39. Rott O, Fleischer B, Cash E. Interleukin-10 prevents experimental allergic encephalomyelitis in rats. Eur. J. Immunol. 1994; 24: 1434-40.
40. Laethem J-LV. Interleukin 10 prevents necrosis in murine experimental acute pancreatitis. Gastroenterology 1995; 108: 1917-22.
41. Pennline KJ. Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse. Clin. Immunol. Immunopathol. 1994; 71: 169-75.
42. Grewe M, Bruijnzeel-Koomen CAFM, Schöpf E et al. A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. Immunol. Today 1998; 19: 359-61.
43. Heinzel FP, Sasick MD, Holaday BJ, Coffman RL, Locksley RM. Reciprocal expression of interferon-γ and interleukin-4 during resolution or progression of murine leishmaniasis: Evidence for expansion of distinct helper T cell subsets. J. Exp. Med. 1995; 169: 59-72.
44. Papadopoulou G, Karagouni E, Dotsika E. ISCOMs vaccine against experimental leishmaniasis. Vaccine 1998; 16: 885-92.
45. Allen JE, Maizels RM. Th1-Th2: Reliable paradigm or dangerous dogma? Immunol. Today 1997; 18: 387-92.
46. Thompson K, Maltby J, Fallowfield J, McAulay M, Millward-Sadler H, Sheron N. Interleukin-10 expression and function in experimental murine liver inflammation and fibrosis. Hepatology 1998; 28: 1597-606.
47. Louis H, Laethem J-LV, Wu W et al. Interleukin-10 controls neutrophilic infiltration, hepatocyte proliferation, and liver fibrosis induced by carbon tetrachloride in mice. Hepatology 1998; 28: 1607-15.
48. Saitoh T, Fujiwara M. Hepatic lesions induced by graft-versus-host reaction across MHC class II antigens: An implication for animal model of primary biliary cirrhosis. Clin. Immunol Immunopathol. 1988; 49: 166-72.
49. Inoue K, Hirohara J, Nakano T et al. Prediction of prognosis of primary biliary cirrhosis in Japan. Liver 1995; 15: 70-7.